Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.
PLoS One.
2013;8(2):e57402. doi: 10.1371/journal.pone.0057402. Epub 2013 Feb 25. PubMed PMID:
23451220; PubMed Central PMCID:
PMC3581440.
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
Ann Am Thorac Soc.
2014 Jan;11(1):36-44. doi: 10.1513/AnnalsATS.201309-310OC. PubMed PMID:
24251858; PubMed Central PMCID:
PMC3972987.
Advances in the diagnosis and treatment of cystic fibrosis.
Adv Pediatr.
2014 Aug;61(1):225-43. doi: 10.1016/j.yapd.2014.03.002. Epub 2014 May 3. Review. PubMed PMID:
25037130.
Nontuberculous mycobacterial infections in cystic fibrosis.
Clin Chest Med.
2015 Mar;36(1):101-15. doi: 10.1016/j.ccm.2014.11.003. Review. PubMed PMID:
25676523.
Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
Clin Chest Med.
2016 Mar;37(1):83-96. doi: 10.1016/j.ccm.2015.11.001. Epub 2015 Dec 23. Review. PubMed PMID:
26857770.
Cystic fibrosis: a model system for precision medicine.
Curr Opin Pediatr.
2016 Jun;28(3):312-7. doi: 10.1097/MOP.0000000000000351. Review. PubMed PMID:
27031658; PubMed Central PMCID:
PMC4946574.
Nontuberculous mycobacterial infections in cystic fibrosis: to treat or not to treat?.
Curr Opin Pulm Med.
2016 Nov;22(6):629-36. doi: 10.1097/MCP.0000000000000317. Review. PubMed PMID:
27583673.
Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors.
Thromb Res.
2017 Oct;158:161-166. doi: 10.1016/j.thromres.2017.08.022. Epub 2017 Sep 5. PubMed PMID:
28934665.
Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
Chest.
2017 Oct;152(4):800-809. doi: 10.1016/j.chest.2017.04.175. Epub 2017 May 5. PubMed PMID:
28483608.
Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.
Pediatr Pulmonol.
2017 Nov;52(S48):S29-S36. doi: 10.1002/ppul.23825. Epub 2017 Sep 7. Review. PubMed PMID:
28881094.
Highlights from the 2017 North American Cystic Fibrosis Conference.
Pediatr Pulmonol.
2018 Jul;53(7):979-986. doi: 10.1002/ppul.24000. Epub 2018 Apr 16. Review. PubMed PMID:
29660839.
Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
Thorac Surg Clin.
2019 Feb;29(1):95-108. doi: 10.1016/j.thorsurg.2018.09.008. Review. PubMed PMID:
30454926.
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review.
J Cyst Fibros.
2019 Mar;18(2):236-243. doi: 10.1016/j.jcf.2019.01.008. Epub 2019 Jan 30. PubMed PMID:
30709744.
A multicenter evaluation of sweat chloride concentration and variation in infants with cystic fibrosis.
J Cyst Fibros.
2019 Mar;18(2):190-193. doi: 10.1016/j.jcf.2018.12.006. Epub 2018 Dec 21. PubMed PMID:
30583934.
Population genomics of nontuberculous mycobacteria recovered from United States cystic fibrosis patients.
bioRxiv. 2019 June.
Highlights from the 2018 North American cystic fibrosis conference.
Pediatr Pulmonol.
2019 Jul;54(7):941-948. doi: 10.1002/ppul.24356. Epub 2019 May 15. PubMed PMID:
31091021.
Prevention of transmission of Mycobacterium abscessus among patients with cystic fibrosis.
Curr Opin Pulm Med.
2019 Nov;25(6):646-653. doi: 10.1097/MCP.0000000000000621. Review. PubMed PMID:
31436542.
Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
Pediatr Pulmonol.
2020 Feb;55(2):521-525. doi: 10.1002/ppul.24604. Epub 2019 Dec 10. Review. PubMed PMID:
31821718; PubMed Central PMCID:
PMC6980303.
What would you like to do?